DNAH17‐AS1 has been shown to promote tumorigenesis and metastatic ability of non‐small cell lung cancer (NSCLC) cells through regulation of miR‐877‐5p/CCNA2 pathway.14 Here, DNAH17 is linked to non-small cell lung carcinoma.